The Gross Margin of Xvivo Perfusion AB (XVIVO.ST) is 74.95%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 74.95% |
| 2023-12-31 | 74.49% |
| 2022-12-31 | 71.51% |
| 2021-12-31 | 72.87% |
| 2020-12-31 | 72.13% |
| 2019-12-31 | 73.73% |
| 2018-12-31 | 72.37% |
| 2017-12-31 | 76.44% |
| 2016-12-31 | 73.99% |
| 2015-12-31 | 70.66% |